Results for tag: "Telavancin"

Telavancin is an antibiotic used to treat serious skin and skin structure infections caused by certain bacteria. It is a lipoglycopeptide antibiotic, which is a type of antibiotic that works by inhibiting the formation of the bacterial cell wall. Telavancin is approved for use in adults and is administered intravenously. It is typically used when other antibiotics have failed or are not suitable for the patient. Telavancin is a relatively new antibiotic and is not widely used. It is mainly used in hospitals and other healthcare settings, and is not available for use in the home. The market for telavancin is relatively small, but it is growing as more healthcare providers become aware of its potential benefits. Companies in the telavancin market include AstraZeneca, Pfizer, Merck, and GlaxoSmithKline. These companies are involved in the research, development, and marketing of telavancin. Show Less Read more